The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more.
Source link
Check latest article from this author !


Recent Posts
- Avtar Human Capital Trust organises India’s First Male Allyship Synergy Summit (MASS) for Students and Corporates
- Min. Chandrima Bhattacharya on Behalf of Ekannoborti Celebrating Womanhood with Hospitality Studies: An Initiative by Xaviers & Chowman
- Be Well Hospitals, Poonamallee Successfully Performs Complex 10-Hour Cytoreductive Surgery with HIPEC for Advanced Appendix Cancer
- The Art of Living & Chhattisgarh Government Join Hands for Holistic Development
- Dr. Ishari. K. Ganesh Founder Chancellor of VISTAS Donates Rs. 10,00,000 to World Carrom Champion Ms. Khazima on International Women’s Day